IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $933,000 | +102.8% | 24,323 | +0.3% | 0.00% | +100.0% |
Q2 2023 | $460,000 | +22.3% | 24,247 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $376,000 | -12.8% | 24,247 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $431,000 | +219.3% | 24,247 | 0.0% | 0.00% | – |
Q3 2022 | $135,000 | +43.6% | 24,247 | 0.0% | 0.00% | – |
Q2 2022 | $94,000 | -29.9% | 24,247 | 0.0% | 0.00% | – |
Q1 2022 | $134,000 | -35.0% | 24,247 | 0.0% | 0.00% | – |
Q4 2021 | $206,000 | -1.4% | 24,247 | +427.1% | 0.00% | -100.0% |
Q4 2020 | $209,000 | – | 4,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |